𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evidence of prostate cancer screening in a UK region

✍ Scribed by A. Gavin; P. McCarron; R.J. Middleton; G. Savage; D. Catney; D. O'Reilly; P.F. Keane; L.J. Murray

Book ID
109050953
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
82 KB
Volume
93
Category
Article
ISSN
1464-4096

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CONTROVERSIES IN PROSTATE CANCER SCREENI
CONTROVERSIES IN PROSTATE CANCER SCREENING
✍ MURPHY, ALANA M.; McKIERNAN, JAMES M.; OLSSON, CARL A. πŸ“‚ Article πŸ“… 2004 πŸ› Lippincott Williams and Wilkins 🌐 English βš– 63 KB
Prostate-specific antigen in screening o
Prostate-specific antigen in screening of prostate cancer
✍ Dr. T. Ming Chu πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 467 KB πŸ‘ 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren

Screening for prostate cancer in Dutch h
Screening for prostate cancer in Dutch hereditary prostate cancer families
✍ Lambertus A. Kiemeney; Mireille J. Broeders; Marjon Pelger; Paul J. Kil; Fritz H πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 137 KB

## Abstract It is common belief that in families with hereditary prostate cancer (HPC), unaffected men should be screened periodically with PSA, but little is known about the effects of such screening. We studied test and tumor characteristics in unaffected 50–75‐year‐old screenees from HPC familie